Genmab A (GMAB) Notes Payables: 2018-2020

Historic Notes Payables for Genmab A (GMAB) over the last 3 years, with Dec 2020 value amounting to $35,770.

  • Genmab A's Notes Payables rose 57.13% to $35,770 in Q4 2020 from the same period last year, while for Dec 2020 it was $35,770, marking a year-over-year increase of 57.13%. This contributed to the annual value of $35,770 for FY2020, which is 57.13% up from last year.
  • Genmab A's Notes Payables amounted to $35,770 in FY2020, which was up 57.13% from $22,765 recorded in FY2019.
  • In the past 5 years, Genmab A's Notes Payables ranged from a high of $18.6 billion in FY2018 and a low of $22,765 during FY2019.
  • Over the past 3 years, Genmab A's median Notes Payables value was $35,770 (recorded in 2020), while the average stood at $6.2 billion.
  • Per our database at Business Quant, Genmab A's Notes Payables slumped by 100.00% in 2019 and then soared by 57.13% in 2020.
  • Genmab A's Notes Payables (Yearly) stood at $18.6 billion in 2018, then crashed by 100.00% to $22,765 in 2019, then surged by 57.13% to $35,770 in 2020.